AnaptysBio
ANAB
ANAB
133 hedge funds and large institutions have $658M invested in AnaptysBio in 2024 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 40 increasing their positions, 41 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% less capital invested
Capital invested by funds: $659M → $658M (-$1.28M)
2% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 41
6.61% less ownership
Funds ownership: 115.81% → 109.2% (-6.6%)
Holders
133
Holding in Top 10
4
Calls
$1.47M
Puts
$1.41M
Top Buyers
| 1 | +$17.2M | |
| 2 | +$15.5M | |
| 3 | +$5.41M | |
| 4 |
SC
Stempoint Capital
New York
|
+$5.06M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.72M |
Top Sellers
| 1 | -$33.9M | |
| 2 | -$15.5M | |
| 3 | -$14M | |
| 4 |
Morgan Stanley
New York
|
-$12.8M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$7.6M |